WHO Endorses a New Single-Dose HPV Vaccine
The World Health Organization (WHO) announced on Oct. 4, 2024 that it has prequalified its fifth human papillomavirus (HPV) vaccine, Cecolin. Cecolin is the only vaccine approved for a single-dose regimen, setting it apart from multi-dose HPV vaccine options like Merck’s Gardasil vaccine, which typically requires three doses, and Walrinvax vaccine, which is manufactured by […]
Chinese Pharmaceutical Industry Competes for Vaccine Market Share
China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to start selling their own version of drugs previously available only through global pharmaceutical giants Pfizer, Merck and GlaxoSmithKline.1 Cecolin, developed by Innovax, will compete in the Human Papilloma Virus (HPV) arena against Merck’s Gardasil and […]
